NKTR, CLNO, XXIA, HILL - NASDAQ Stock News! From PennyGovernance.com
Nektar Therapeutics (Nasdaq:NKTR) reported its financial results for the second quarter ended June 30, 2011. Cash, cash equivalents, and investments at June 30, 2011 were $481.8 million as compared to $315.9 million at December 31, 2010.
There is more on this article and other NASDAQ news available at: http://pennygovernance.com/?p=16226